Guangzhou Bai Rui Kang Biological Science and Technology

Guangzhou Bairuikang Biological Technology is a Chinese biopharmaceutical company specializing in the research, development, and manufacturing of human vaccines. Founded in 2009 and headquartered in Guangzhou's Science City, the company focuses on addressing critical public health needs through advanced biological production. Its flagship product is a human rabies vaccine (Vero cell), which utilizes large-scale bioreactor technology to ensure high purity and potency. The company operates state-of-the-art manufacturing facilities that adhere to national Good Manufacturing Practice (GMP) standards. Bairuikang is committed to expanding its product pipeline to include other viral vaccines and innovative immunization solutions. Through its focus on quality and technological innovation, the company has established itself as a significant player in the domestic Chinese vaccine market.